1
|
Asahara T, Murohara T, Sullivan A, Silver
M, van Der Zee R, Li T, Witzenbichler B, Schatteman G and Isner JM:
Isolation of putative progenitor endothelial cells for
angiogenesis. Science. 275:964–967. 1997. View Article : Google Scholar : PubMed/NCBI
|
2
|
Fan Y, Shen F, Frenzel T, Zhu W, Ye J, Liu
J, Chen Y, Su H, Young WL and Yang GY: Endothelial progenitor cell
transplantation improves long-term stroke outcome in mice. Ann
Neurol. 67:488–497. 2010. View Article : Google Scholar : PubMed/NCBI
|
3
|
Bhattacharya V, McSweeney PA, Shi Q, Bruno
B, Ishida A, Nash R, Storb RF, Sauvage LR, Hammond WP and Wu MH:
Enhanced endothelialization and microvessel formation in polyester
grafts seeded with CD34+ bone marrow cells. Blood.
95:581–585. 2000.PubMed/NCBI
|
4
|
Zhao YD, Courtman DW, Deng Y, Kuqathasan
L, Zhang Q and Stewart DJ: Rescue of monocrotaline-induced
pulmonary arterial hypertension using bone marrow-derived
endothelial-like progenitor cells: efficacy of combined cell and
eNOS gene therapy in established disease. Circ Res. 96:442–450.
2005. View Article : Google Scholar
|
5
|
Diller GP, van Eijl S, Okonko DO, Howard
LS, Ali O, Thum T, Wort SJ, Bédard E, Gibbs JS, Bauersachs J, et
al: Circulating endothelial progenitor cells in patients with
Eisenmenger syndrome and idiopathic pulmonary arterial
hypertension. Circulation. 117:3020–3030. 2008. View Article : Google Scholar : PubMed/NCBI
|
6
|
Junhui Z, Xingxiang W, Guosheng F, Yunpeng
S, Furong Z and Junzhu C: Reduced number and activity of
circulating endothelial progenitor cells in patients with
idiopathic pulmonary arterial hypertension. Respir Med.
102:1073–1079. 2008. View Article : Google Scholar : PubMed/NCBI
|
7
|
Nagaya N, Kangawa K, Kanda M, Uematsu M,
Horio T, Fukuyama N, Hino J, Harada-Shiba M, Okumura H, Tabata Y,
et al: Hybrid cell-gene therapy for pulmonary hypertension based on
phagocytosing action of endothelial progenitor cells. Circulation.
108:889–895. 2003. View Article : Google Scholar : PubMed/NCBI
|
8
|
Ohki Y, Heissig B, Sato Y, Akiyama H, Zhu
Z, Hicklin DJ, Shimada K, Ogawa H, Daida H, Hattori K and Ohsaka A:
Granulocyte colony-stimulating factor promotes neovascularization
by releasing vascular endothelial growth factor from neutrophils.
FASEB J. 19:2005–2007. 2005.
|
9
|
Maruyama H, Watanabe S, Kimura T, Liang J,
Nagasawa T, Onodera M, Aonuma K and Yamaguchi I: Granulocyte
colony-stimulating factor prevents progression of
monocrotaline-induced pulmonary arterial hypertension in rats. Circ
J. 71:138–143. 2007. View Article : Google Scholar : PubMed/NCBI
|
10
|
Aicher A, Heeschen C, Mildner-Rihm C,
Urbich C, Ihling C, Technau-Ihling K, Zeiher AM and Dimmeler S:
Essential role of endothelial nitric oxide synthase for
mobilization of stem and progenitor cells. Nat Med. 9:1370–1376.
2003. View Article : Google Scholar : PubMed/NCBI
|
11
|
Laufs U, Werner N, Link A, Endres M,
Wassmann S, Jürgens K, Miche E, Böhm M and Nickenig G: Physical
training increases endothelial progenitor cells, inhibits neointima
formation, and enhances angiogenesis. Circulation. 109:220–226.
2004. View Article : Google Scholar
|
12
|
Fukumura D, Gohongi T, Kadambi A, Izumi Y,
Ang J, Yun CO, Buerk DG, Huang PL and Jain RK: Predominant role of
endothelial nitric oxide synthase in vascular endothelial growth
factor-induced angiogenesis and vascular permeability. Proc Natl
Acad Sci USA. 98:2604–2609. 2001. View Article : Google Scholar
|
13
|
Guthrie SM, Curtis LM, Mames RN, Simon GG,
Grant MB and Scott EW: The nitric oxide pathway modulates
hemangioblast activity of adult hematopoietic stem cells. Blood.
105:1916–1922. 2005. View Article : Google Scholar : PubMed/NCBI
|
14
|
Ueda K, Takano H, Hasegawa H, Niitsuma Y,
Qin Y, Ohtsuka M and Komuro I: Granulocyte colony stimulating
factor directly inhibits myocardial ischemia-reperfusion injury
through Akt-endothelial NO synthase pathway. Arterioscler Thromb
Vasc Biol. 26:e108–113. 2006. View Article : Google Scholar
|
15
|
Shimada K, Okabe TA, Mikami Y, Hattori M,
Fujita M and Kishimoto C: Therapy with granulocyte
colony-stimulating factor in the chronic stage, but not in the
acute stage, improves experimental autoimmune myocarditis in rats
via nitric oxide. J Mol Cell Cardiol. 49:469–481. 2010. View Article : Google Scholar
|
16
|
Matsuda Y, Hoshikawa Y, Ameshima S, Suzuki
S, Okada Y, Tabata T, Sugawara T, Matsumura Y and Kondo T: Effects
of peroxisome proliferator-activated receptor gamma ligands on
monocrotaline-induced pulmonary hypertension in rats. Nihon Kokyuki
Gakkai Zasshi. 43:283–288. 2005.(In Japanese).
|
17
|
Chakroborty D, Chowdhury UR, Sarkar C,
Baral R, Dasgupta PS and Basu S: Dopamine regulates endothelial
progenitor cell mobilization from mouse bone marrow in tumor
vascularization. J Clin Invest. 118:1380–1389. 2008. View Article : Google Scholar : PubMed/NCBI
|
18
|
Xu MG, Men LN, Zhao CY, Zhao X, Wang YX,
Meng XC, Shen DR, Meng BY, Zhang Q and Wang T: The number and
function of circulating endothelial progenitor cells in patients
with Kawasaki disease. Eur J Pediatr. 169:289–296. 2010. View Article : Google Scholar : PubMed/NCBI
|
19
|
Gurbanov E and Shiliang X: The key role of
apoptosis in the pathogenesis and treatment of pulmonary
hypertension. Eur J Cardiothorac Surg. 30:499–507. 2006. View Article : Google Scholar : PubMed/NCBI
|
20
|
Tuder RM, Marecki JC, Richter A,
Fijalkowska I and Flores S: Pathology of pulmonary hypertension.
Clin Chest Med. 28:23–42. 2007. View Article : Google Scholar
|
21
|
Budhiraja R, Tuder RM and Hassoun PM:
Endothelial dysfunction in pulmonary hypertension. Circulation.
109:159–165. 2004. View Article : Google Scholar : PubMed/NCBI
|
22
|
Ormiston ML, Deng Y, Stewart DJ and
Courtman DW: Innate immunity in the therapeutic actions of
endothelial progenitor cells in pulmonary hypertension. Am J Respir
Cell Mol Biol. 43:546–554. 2010. View Article : Google Scholar : PubMed/NCBI
|
23
|
Takahashi M, Nakamura T, Toba T, Kajiwara
N, Kato H and Shimizu Y: Transplantation of endothelial progenitor
cells into the lung to alleviate pulmonary hypertension in dogs.
Tissue Eng. 10:771–779. 2004. View Article : Google Scholar : PubMed/NCBI
|
24
|
Valgimigli M, Rigolin GM, Fucili A, Porta
MD, Soukhomovskaia O, Malagutti P, Bugli AM, Bragotti LZ,
Francolini G, Mauro E, et al: CD34+ and endothelial
progenitor cells in patients with various degrees of congestive
heart failure. Circulation. 110:1209–1212. 2004.
|
25
|
Kissel CK, Lehmann R, Assmus B, Aicher A,
Honold J, Fischer-Rasokat U, Heeschen C, Spyridopoulos I, Dimmeler
S and Zeiher AM: Selective functional exhaustion of hematopoietic
progenitor cells in the bone marrow of patients with postinfarction
heart failure. J Am Coll Cardiol. 49:2341–2349. 2007. View Article : Google Scholar : PubMed/NCBI
|
26
|
Powell TM, Paul JD, Hill JM, Thompson M,
Benjamin M, Rodrigo M, McCoy JP, Read EJ, Khuu HM, Leitman SF, et
al: Granulocyte colony-stimulating factor mobilizes functional
endothelial progenitor cells in patients with coronary artery
disease. Arterioscler Thromb Vasc Biol. 25:296–301. 2005.
View Article : Google Scholar
|
27
|
Kovacic JC, Muller DW and Graham RM:
Actions and therapeutic potential of G-CSF and GM-CSF in
cardiovascular disease. J Mol Cell Cardiol. 42:19–33. 2007.
View Article : Google Scholar : PubMed/NCBI
|